Relugolix combination therapy for endometriosis pain

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (12)

• Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex
• Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
• Hormone treatment of endometriosis: the estrogen threshold hypothesis via openalex
• Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
• O-132 Sustained efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT 52-week data via openalex
• Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) via openalex
• W4200280437 via openalex
• W2163315477 via openalex
• W2757350733 via openalex
• W2132577372 via openalex
• W6800149184 via openalex

Cited by (2)

• Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of Hormonal Agents 2024
• Managing the neuroinflammatory pain of endometriosis in light of chronic pelvic pain 2024

Source provenance

europepmc

last seen: 2026-10-19T06:17:24.038039+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-10-08T21:35:38.388284+00:00

unpaywall

last seen: 2026-10-19T06:34:38.229974+00:00